Randomized Trial of Intraoperative IV Versus Preoperative Oral Acetaminophen During Ambulatory Lumbar Discectomy
Randomized Trial of IV Versus Oral Acetaminophen for Ambulatory Lumbar Discectomy or Single-level Decompression
1 other identifier
interventional
82
1 country
1
Brief Summary
Effective non-opioid analgesics are of particular interest in ambulatory surgery, as providers may be able to reduce pain while avoiding perioperative opioids that can delay same day discharge. The value of maintaining an efficient flow of patients from the perioperative area to discharge is an important metric for same day surgery centers, and an improvement in efficiency with IV acetaminophen could potentially offset the increased cost of the medication while providing a more pleasant surgical experience for patients. The goal of this study is to compare the efficacy of intraoperative IV administration vs. preoperative oral administration of acetaminophen on postoperative opioid utilization, patient-reported pain scores, opioid-related adverse effects, and time to recovery and discharge from the post-anesthesia care unit (PACU) after ambulatory lumbar discectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Mar 2021
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2020
CompletedFirst Posted
Study publicly available on registry
October 5, 2020
CompletedStudy Start
First participant enrolled
March 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedJanuary 12, 2024
January 1, 2024
3.6 years
September 29, 2020
January 10, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative opioid usage
Postoperative opioid usage over the first 24 hours will be reported in IV morphine equivalents
1 day
Secondary Outcomes (3)
Quality of recovery
1 day
Number of patients who report nausea or vomiting
1 day
Mean pain score
1 day
Study Arms (2)
Group 1: IV acetaminophen and PO placebo
ACTIVE COMPARATORGroup 1 will receive 1000 mg of IV acetaminophen approximately 30 minutes prior to skin closure and will receive oral placebo in the holding area prior to surgery
Group 2: PO acetaminophen
ACTIVE COMPARATORGroup 2 will receive 1000 mg of PO acetaminophen in the holding area and will not receive an IV placebo.
Interventions
1000 mg of oral acetaminophen preoperatively administered
Eligibility Criteria
You may qualify if:
- Age greater than 18 years-old
- Weight greater than 50 kg body weight
- ASA physical status I-III
- English-speaking
You may not qualify if:
- Weight less than 50 kg
- Pregnancy or breast feeding
- revision surgery
- Contraindications to the administration of acetaminophen (e.g. allergy, liver failure, etc)
- Chronic pain conditions unrelated to back pain
- Opioid tolerance ( defined as taking greater than oxycodone 20 mg daily for a week during the past month).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, 19107, United States
Related Publications (1)
Schwenk ES, Ferd P, Torjman MC, Li CJ, Charlton AR, Yan VZ, McCurdy MA, Kepler CK, Schroeder GD, Fleischman AN, Issa T. Intravenous versus oral acetaminophen for pain and quality of recovery after ambulatory spine surgery: a randomized controlled trial. Reg Anesth Pain Med. 2025 Jun 10;50(6):483-488. doi: 10.1136/rapm-2024-105386.
PMID: 38499358DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Only those performing postoperative assessments and the participants will be blinded.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2020
First Posted
October 5, 2020
Study Start
March 18, 2021
Primary Completion
October 31, 2024
Study Completion
October 31, 2024
Last Updated
January 12, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share